Franchises et coassurance : Questions médicales fréquentes
Nom anglais: Deductibles and Coinsurance
Descriptor UI:D003669
Tree Number:N03.219.521.576.090.300
Termes MeSH sélectionnés :
Immunity
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Franchises et coassurance : Questions médicales les plus fréquentes",
"headline": "Franchises et coassurance : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Franchises et coassurance : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-08",
"dateModified": "2025-04-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Franchises et coassurance"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Participation aux coûts",
"url": "https://questionsmedicales.fr/mesh/D017047",
"about": {
"@type": "MedicalCondition",
"name": "Participation aux coûts",
"code": {
"@type": "MedicalCode",
"code": "D017047",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.219.521.576.090"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Franchises et coassurance",
"alternateName": "Deductibles and Coinsurance",
"code": {
"@type": "MedicalCode",
"code": "D003669",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "J Frank Wharam",
"url": "https://questionsmedicales.fr/author/J%20Frank%20Wharam",
"affiliation": {
"@type": "Organization",
"name": "Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA."
}
},
{
"@type": "Person",
"name": "Alisa B Busch",
"url": "https://questionsmedicales.fr/author/Alisa%20B%20Busch",
"affiliation": {
"@type": "Organization",
"name": "Department of Health Care Policy, Harvard Medical School."
}
},
{
"@type": "Person",
"name": "Fang Zhang",
"url": "https://questionsmedicales.fr/author/Fang%20Zhang",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Dennis Ross-Degnan",
"url": "https://questionsmedicales.fr/author/Dennis%20Ross-Degnan",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Mark K Meiselbach",
"url": "https://questionsmedicales.fr/author/Mark%20K%20Meiselbach",
"affiliation": {
"@type": "Organization",
"name": "Health Policy and Management, Johns Hopkins University, Baltimore, Maryland, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Boosting the Immune Response-Combining Local and Immune Therapy for Prostate Cancer Treatment.",
"datePublished": "2022-09-07",
"url": "https://questionsmedicales.fr/article/36139368",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/cells11182793"
}
},
{
"@type": "ScholarlyArticle",
"name": "The omics strategy: the use of systems vaccinology to characterize immune responses to childhood immunization.",
"datePublished": "2022-07-05",
"url": "https://questionsmedicales.fr/article/35786291",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/14760584.2022.2093193"
}
},
{
"@type": "ScholarlyArticle",
"name": "Regulation of immune responses in primary biliary cholangitis: a transcriptomic analysis of peripheral immune cells.",
"datePublished": "2023-04-04",
"url": "https://questionsmedicales.fr/article/37026715",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/HC9.0000000000000110"
}
},
{
"@type": "ScholarlyArticle",
"name": "Seroepidemiology of measles in immune generation in Taiwan: Prevalence of neutralizing antibody and immune response to reimmunization.",
"datePublished": "2023-01-19",
"url": "https://questionsmedicales.fr/article/36707365",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jmii.2023.01.012"
}
},
{
"@type": "ScholarlyArticle",
"name": "The role of immune cells and associated immunological factors in the immune response to spinal cord injury.",
"datePublished": "2023-01-05",
"url": "https://questionsmedicales.fr/article/36685599",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.1070540"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Organisations et économie des soins de santé",
"item": "https://questionsmedicales.fr/mesh/D004472"
},
{
"@type": "ListItem",
"position": 3,
"name": "Économie",
"item": "https://questionsmedicales.fr/mesh/D004467"
},
{
"@type": "ListItem",
"position": 4,
"name": "Financement organisé",
"item": "https://questionsmedicales.fr/mesh/D005381"
},
{
"@type": "ListItem",
"position": 5,
"name": "Assurance",
"item": "https://questionsmedicales.fr/mesh/D007341"
},
{
"@type": "ListItem",
"position": 6,
"name": "Participation aux coûts",
"item": "https://questionsmedicales.fr/mesh/D017047"
},
{
"@type": "ListItem",
"position": 7,
"name": "Franchises et coassurance",
"item": "https://questionsmedicales.fr/mesh/D003669"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Franchises et coassurance - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Franchises et coassurance",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Franchises et coassurance",
"description": "Qu'est-ce qu'une franchise en assurance santé ?\nComment fonctionne la coassurance ?\nQuelle est la différence entre franchise et coassurance ?\nComment sont calculées les franchises ?\nLes franchises sont-elles remboursables ?",
"url": "https://questionsmedicales.fr/mesh/D003669?mesh_terms=Immunity&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Franchises et coassurance",
"description": "Quels sont les impacts d'une franchise élevée ?\nComment la coassurance affecte-t-elle les patients ?\nLes patients ressentent-ils du stress à cause des franchises ?\nLes franchises influencent-elles la santé des patients ?\nY a-t-il des symptômes financiers liés à la coassurance ?",
"url": "https://questionsmedicales.fr/mesh/D003669?mesh_terms=Immunity&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Franchises et coassurance",
"description": "Comment éviter des frais élevés de franchise ?\nLes bilans de santé sont-ils couverts sans franchise ?\nComment éduquer les patients sur les franchises ?\nLes programmes de prévention réduisent-ils les coûts ?\nComment les patients peuvent-ils planifier leurs soins ?",
"url": "https://questionsmedicales.fr/mesh/D003669?mesh_terms=Immunity&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Franchises et coassurance",
"description": "Comment choisir un plan avec franchise ?\nLes traitements préventifs sont-ils couverts ?\nComment réduire les coûts de coassurance ?\nLes médicaments sont-ils soumis à la franchise ?\nLes soins d'urgence sont-ils affectés par la coassurance ?",
"url": "https://questionsmedicales.fr/mesh/D003669?mesh_terms=Immunity&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Franchises et coassurance",
"description": "Quelles complications peuvent survenir avec des franchises élevées ?\nLa coassurance peut-elle entraîner des complications financières ?\nLes patients évitent-ils des soins à cause des coûts ?\nComment les complications de santé affectent-elles les coûts ?\nLes complications dues à la coassurance sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D003669?mesh_terms=Immunity&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Franchises et coassurance",
"description": "Quels facteurs augmentent les coûts de franchise ?\nComment le choix de l'assurance affecte-t-il les coûts ?\nLes maladies chroniques augmentent-elles les frais ?\nLes jeunes adultes ont-ils des franchises plus basses ?\nLes habitudes de santé influencent-elles les coûts ?",
"url": "https://questionsmedicales.fr/mesh/D003669?mesh_terms=Immunity&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Qu'est-ce qu'une franchise en assurance santé ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est le montant que le patient doit payer avant que l'assurance ne couvre les frais."
}
},
{
"@type": "Question",
"name": "Comment fonctionne la coassurance ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est le pourcentage des frais médicaux que le patient doit payer après la franchise."
}
},
{
"@type": "Question",
"name": "Quelle est la différence entre franchise et coassurance ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La franchise est un montant fixe, tandis que la coassurance est un pourcentage des frais."
}
},
{
"@type": "Question",
"name": "Comment sont calculées les franchises ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont généralement fixées par le contrat d'assurance et varient selon les plans."
}
},
{
"@type": "Question",
"name": "Les franchises sont-elles remboursables ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les montants de franchise ne sont pas remboursés par l'assurance."
}
},
{
"@type": "Question",
"name": "Quels sont les impacts d'une franchise élevée ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une franchise élevée peut dissuader les patients de consulter des soins médicaux."
}
},
{
"@type": "Question",
"name": "Comment la coassurance affecte-t-elle les patients ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des coûts supplémentaires pour les patients lors de soins médicaux."
}
},
{
"@type": "Question",
"name": "Les patients ressentent-ils du stress à cause des franchises ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les coûts imprévus peuvent causer de l'anxiété financière chez les patients."
}
},
{
"@type": "Question",
"name": "Les franchises influencent-elles la santé des patients ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent limiter l'accès aux soins, affectant ainsi la santé globale des patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes financiers liés à la coassurance ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des frais médicaux imprévus peuvent entraîner des difficultés financières."
}
},
{
"@type": "Question",
"name": "Comment éviter des frais élevés de franchise ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Choisissez un plan avec une franchise adaptée à vos besoins médicaux prévisibles."
}
},
{
"@type": "Question",
"name": "Les bilans de santé sont-ils couverts sans franchise ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Souvent, les bilans de santé préventifs sont couverts sans frais de franchise."
}
},
{
"@type": "Question",
"name": "Comment éduquer les patients sur les franchises ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fournissez des informations claires sur les coûts et les options d'assurance disponibles."
}
},
{
"@type": "Question",
"name": "Les programmes de prévention réduisent-ils les coûts ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent réduire les coûts à long terme en évitant des soins coûteux."
}
},
{
"@type": "Question",
"name": "Comment les patients peuvent-ils planifier leurs soins ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils doivent évaluer leurs besoins et choisir des soins en fonction de leur plan d'assurance."
}
},
{
"@type": "Question",
"name": "Comment choisir un plan avec franchise ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluez vos besoins médicaux et comparez les coûts des franchises et coassurances."
}
},
{
"@type": "Question",
"name": "Les traitements préventifs sont-ils couverts ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Souvent, les traitements préventifs sont couverts sans franchise, selon le plan."
}
},
{
"@type": "Question",
"name": "Comment réduire les coûts de coassurance ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Choisissez des soins dans le réseau de votre assurance pour réduire les frais."
}
},
{
"@type": "Question",
"name": "Les médicaments sont-ils soumis à la franchise ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent être soumis à la franchise selon le plan d'assurance."
}
},
{
"@type": "Question",
"name": "Les soins d'urgence sont-ils affectés par la coassurance ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les soins d'urgence peuvent entraîner des frais de coassurance après la franchise."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des franchises élevées ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients peuvent retarder des soins nécessaires, entraînant des complications de santé."
}
},
{
"@type": "Question",
"name": "La coassurance peut-elle entraîner des complications financières ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des frais imprévus peuvent causer des dettes médicales importantes."
}
},
{
"@type": "Question",
"name": "Les patients évitent-ils des soins à cause des coûts ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les coûts élevés peuvent dissuader les patients de rechercher des soins médicaux."
}
},
{
"@type": "Question",
"name": "Comment les complications de santé affectent-elles les coûts ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications peuvent entraîner des frais médicaux supplémentaires et imprévus."
}
},
{
"@type": "Question",
"name": "Les complications dues à la coassurance sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreux patients rencontrent des difficultés à payer leurs frais médicaux."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent les coûts de franchise ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, les antécédents médicaux et le type de soins peuvent influencer les coûts."
}
},
{
"@type": "Question",
"name": "Comment le choix de l'assurance affecte-t-il les coûts ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Différents plans d'assurance ont des franchises et coassurances variées, influençant les coûts."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles les frais ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients avec des maladies chroniques peuvent faire face à des frais plus élevés."
}
},
{
"@type": "Question",
"name": "Les jeunes adultes ont-ils des franchises plus basses ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Souvent, les jeunes adultes choisissent des plans avec des franchises plus basses."
}
},
{
"@type": "Question",
"name": "Les habitudes de santé influencent-elles les coûts ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes de santé positives peuvent réduire les frais médicaux à long terme."
}
}
]
}
]
}
Due to its slow progression and susceptibility to radical forms of treatment, low-grade PC is associated with high overall survival (OS). With the clinical progression of PC, the therapy is becoming m...
Vaccines have had a transformative impact on child health. Despite this impact, the immunological processes involved in protective responses are not entirely understood and vaccine development has bee...
Systems level information and tools are now being deployed by vaccinologists at all stages of the vaccine development pathway; however, this review will specifically describe some of the key findings ...
Despite the success of vaccines, there remains hard-to-target pathogens, refractory to current vaccination strategies. Moreover, zoonotic diseases with pandemic potential are a threat to global health...
In patients with primary biliary cholangitis (PBC), the serum liver biochemistry measured during treatment with ursodeoxycholic acid-the UDCA response-accurately predicts long-term outcome. Molecular ...
We performed bulk RNA-sequencing of monocytes and TH1, TH17, TREG, and B cells isolated from the peripheral blood of 15 PBC patients with adequate UDCA response ("responders"), 16 PBC patients with in...
Using the Weighted Gene Co-expression Network Analysis, we identified modules associated with response and/or disease status (q<0.05) in each peripheral blood mononuclear cell subset. Hub genes and fu...
We provide evidence that adaptive immune responses are better regulated in patients with PBC with adequate UDCA response....
Secondary vaccine failure was the principal mechanic of measles reemergence in countries with high measles vaccine coverage. The information on neutralizing antibody (nAb) prevalence, epidemiological ...
The nAb and factors of wanned immunity to measles were evaluated in a cohort of 333 subjects aged 11-30 years in 2010. The longitudinal immune response to reimmunization (n = 30) and potential virus e...
In the 2010 cohort, the susceptibility to measles diseases and infections was respectively identified in 35 (10.5%) and 226 (67.9%) subjects. A generalized linear model identified earlier ages of firs...
A lack of protective immunity to measles diseases might be identified in 10% of the Taiwanese population aged 11-30 years and associated with a trend toward earlier ages of the first measles vaccinati...
Spinal cord injury (SCI) is a devastating neurological condition prevalent worldwide. Where the pathological mechanisms underlying SCI are concerned, we can distinguish between primary injury caused b...
Cholera is an enteric disease caused by...
In this review, we revisit clinical trials which are focused on the early transcriptional mucosal responses elicited during...
The inability of currently licensed killed/inactivated vaccines to elicit key inflammatory pathways locally may explain their restricted efficacy in endemic settings. More studies are required to unde...
The immune-inflammatory response is associated with increased nitro-oxidative stress. The aim of this mechanistic review is to examine: (a) the role of redox-sensitive transcription factors and enzyme...
The study of metabolism provides important information for understanding the biological basis of cancer cells and the defects of cancer treatment. Disorders of polyamine metabolism is a common metabol...
The tumor microenvironment (TME) is a crucial driving factor for tumor progression and it can hinder the body's immune response by altering the metabolic activity of immune cells. Both tumor and immun...